Biotechnology Business
Celera Reports First Quarter Fiscal 2008 Results
Published in Drug Law Weekly, November 6th, 2007
Celera Group (NYSE: CRA), an Applera Corporation business, reported revenues of $16.1 million for the first quarter of fiscal 2008, compared to $10.2 million in the prior year quarter. The first quarter fiscal 2008 results included $5.0 million of net revenues related to the achievement of a drug development license milestone by a third party and the resale of a small molecule drug development program as described under Financial Highlights below. For the first quarter of fiscal 2008, Celera reported net income of $0.7 million, or $0.01 per share, compared to a net loss of $7.1 million, or $0.09 per share, for the prior year quarter. The first quarter fiscal 2007 results included a pre-tax...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-11-06)
More Articles from Drug Law Weekly
- Alcoholism
Youth and Health Experts Call on the Governor to Take the Buzz Out of Energy Drinks - Bioengineering
IntelliPharmaCeuitics Ltd. Announces Generic Drug Commercialization Activities - Biopharmaceuticals
Protalix BioTherapeutics Announces Pricing of Public Offering of Common Stock - Biotechnology Business
Biovail Submits Complete Response to FDA for BVF-033 - Bird Flu
The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy - Chronic Obstructive Pulmonary Disease
Clinical Trial Data: Safety/Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
